Psychiatry and Primary CareDoes a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?
Introduction
Depressive disorders in primary care are common and carry substantial morbidity. Major depression, the most severe form of the depressive disorders, has a prevalence of 6%–8%, making it more common than hypertension in this setting [1]. It carries substantial morbidity, matching or exceeding that associated with other common chronic medical conditions [2].
Other depressive disorders less severe than major depression are also fairly common in primary care settings. Dysthymia, a chronic low grade depression lasting at least 2 years, is found in 2.1%–3.7% of primary care patients [3]. Minor depression, defined as two to four depressive symptoms over a 2-week period, is found in 3.6%–9.1% of this population 4, 5. Although frequently seen in the primary care setting and noted as a specific type of subthreshold depressive condition in the Primary Care version of the DSM-IV [6], minor depression is not currently a discrete DSM-IV diagnosis and is included under the category “Depressive disorder not otherwise specified” [7]. Both dysthymia and minor depression, though less severe than major depression, are associated with morbidity nearly as great as that with major depression and much greater than in patients without depressive symptoms 2, 8.
Not surprisingly, primary care clinicians play a pivotal role in managing depressive disorders. They provide nearly half of the outpatient care for patients with depression [9] and record approximately the same number of yearly patient visits for an antidepressant prescription as do psychiatrists [10].
Despite meeting criteria for depressive disorders, patients with depression seen in primary care settings have a milder course than do those seen in specialty mental health settings. Depressive illness may be less severe for the former group, with fewer psychiatric symptoms, a lower likelihood of having received prior treatment for depression, and a lower risk of lifetime psychiatric hospitalization 11, 12. These patients also have a better short-term prognosis, with a higher rate of response to treatment [13] and a greater chance of recovery at 1 year follow-up [12], and this improved prognosis appears independent of whether adequate antidepressant medication is provided [14].
Given that depression is so common and that many patients improve relatively quickly, a key issue for primary care physicians is to determine which patients are at risk for persistent depressive illness. Unfortunately, in primary care settings, there is little knowledge of the factors that influence the likelihood of persistent depression. Identified predictors include depressive severity and high neuroticism scores 3, 15, the presence of dysthymia [16], the presence of comorbid medical illness 3, 17, less education [18], less physical activity, unemployment, and low levels of social support [19], and poor social functioning 17, 20. Of these, only depressive illness and comorbid physical illness appear as potential areas for direct intervention by primary care physicians.
A potential predictor of persistent depression in the primary care setting which has received relatively limited examination is the presence of a coexisting anxiety disorder. Previous primary care research, while suggesting that current coexisting anxiety disorders should not be considered as predictors of persistence in a multivariate analysis, involved only panic disorder and generalized anxiety disorder (GAD), and follow-up was limited to 4 months [15]. A coexisting anxiety disorder remains a good candidate as a predictor of persistence for a number of reasons. First, anxiety disorders have been identified as a predictor of persistent depressive illness in mental health settings, where they have been associated with subsequent depressive morbidity 21, 22, decreased treatment responsiveness 22, 23, 24, 25, and greater social dysfunction [26]. Second, anxiety disorders commonly coexist with major depression in primary care settings, with reports of comorbidity ranging from 28% to 66% 15, 27, 28, 29, 30, 31. GAD is the most common, coexisting in 54%–62% of patients with major depression. Panic disorder co-occurs in 10%–44% and is felt to be the most clinically important. Social phobia and agoraphobia, however, have been less well studied. Most reports on major depression comorbid with an anxiety disorder have either grouped all anxiety disorders together 28, 29, grouped all phobic disorders together [31], screened for (rather than diagnosed) the anxiety disorder [31], or ignored anxiety disorders other than panic disorder and GAD 15, 30.
Third, a lifetime history of either a comorbid panic disorder or GAD does appear to be a risk factor for a worse course of illness in primary care patients with major depression. Patients with a lifetime history of panic disorder have greater depressive severity [32], greater impairment in physical and psychosocial functioning [32], and a poorer response to treatment than those with major depression alone 32, 33. Primary care patients with major depression with a lifetime history of either panic disorder or GAD tend to terminate treatment prematurely more often than those without a comorbid anxiety disorder 32, 33.
Finally, determining whether a coexisting anxiety disorder predicts persistence of depressive symptoms in primary care patients is clinically important. Unlike many other possible predictors of depression, anxiety disorders are treatable. Knowledge of this comorbidity can alert the clinician to a possible need to modify the treatment intervention and to more aggressively manage the patient’s depression.
The following then is our research question: For primary care patients with major depression, does a current coexisting anxiety disorder predict persistent depressive illness at 12-month follow-up?
Section snippets
Design and setting
A prospective cohort study was conducted over a 1-year period with follow-up at 3-month intervals. The setting was a university-based family practice clinic at Duke University Medical Center. Patients with major depression, selected from a larger study focused primarily on minor depression in a primary care setting, were identified and followed. The intent of the original study was to compare the outcomes of patients with minor depression to those with major depression and those without any
Results
Of the 2360 patients eligible for screening, 1916 completed the CES-D screen. Those not completing the screen either refused (335) or were missed (109). Of those completing the screen, 294 scored 16 or above, indicating a positive screen. The DIS was administered by telephone and completed by 282 of those who screened positive. Of those 282, 85 had a diagnosis of major depression. These 85 patients, representing 4.4% of the family practice population completing the screen, became the sample for
Comment
A coexisting anxiety disorder does predict persistent depressive illness in primary care patients with major depression at 12-month follow-up. Though the two groups appeared indistinguishable at baseline, the group with a coexisting anxiety disorder was 44% more likely to have persistent illness 1 year later. None of the other risk factors known to predict persistent depressive illness in either specialty mental health settings or primary care settings altered this relationship. Having a
Acknowledgements
The authors would like to thank the medical staff of the Duke University Family Medicine Center who assisted with patient recruitment, and made severity of illness assessments on all study patients. We would also like to thank Alverta Sigmon, project director, for her superb coordination and assistance and William C. Miller, M.D., Ph.D., and Joanne Garrett, Ph.D., who provided invaluable methodological expertise. Dr. Gaynes was a Robert Wood Johnson Clinical Scholar at the University of North
References (62)
- et al.
Epidemiology of depression in primary care
Gen Hosp Psychiatry
(1992) - et al.
Differences between detected and undetected depressed patients in primary care and depressed psychiatric patients
Gen Hosp Psychiatry
(1996) - et al.
The predictors of persistence of depression in primary care
J Affec Disord
(1994) - et al.
Anxious depressionsclinical, family history, and naturalistic outcome comparisons with panic and major depressive disorders
J Affect Disord
(1984) - et al.
Major depression with and without a coexisting anxiety disordersocial dysfunction, social integration, and personality features
J Affect Disord
(1990) - et al.
Prevalence, nature, and comorbidity of depressive disorders in primary care
Gen Hosp Psychiatry
(1994) - et al.
Major depression in primary care practiceclinical characteristics and treatment implications
Psychosomatics
(1995) - et al.
Agreement between face-to-face and telephone administered versions of the depressive section of the NIMH Diagnostic Interview Schedule
J Psychiatr Res
(1988) - et al.
The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity
J Clin Epidemiol
(1993) - et al.
The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus
J Chronic Dis
(1974)
Competing demands in psychosocial carea model for the identification and treatment of depressive disorders in primary care
Gen Hosp Psychiatry
Major depression in primary care medical practiceresearch trends and future priorities
Gen Hosp Psychiatry
The epidemiology of depression in medical care
Int J Psychiatry Med
The functioning and well-being of depressed patientsresults from the Medical Outcomes Study
JAMA
The prevalence of psychiatric disorders in a primary care practice
Arch Gen Psychiatry
Subthreshold psychiatric symptoms in a primary care group practice
Arch Gen Psychiatry
Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Primary Care Version (DSM-IV-PC)
Diagnostic and Statistical Manual of Mental Disorders
Depression, disability days, and days lost from work in a prospective epidemiologic survey
JAMA
The de facto US mental and addictive disorders service systemepidemiologic catchment area prospective 1-year prevalence rates of disorders and services
Arch Gen Psychiatry
Prescribing trends in psychotropic medicationsprimary care, psychiatry, and other medical specialities
JAMA
Characteristics of patients with major depression who received care in general medical and specialty mental health settings
Med Care
Recognition and management of depression in general practiceconsensus statement
BMJ
Outcomes of “inadequate” antidepressant treatment
J Gen Intern Med
The course of depression in adult outpatientsresults from the Medical Outcomes Study
Arch Gen Psychiatry
Six-month outcomes for medical patients with major depressive disorders
J Gen Intern Med
Psychiatric disorders in primary care
Arch Gen Psychiatry
Personal and psychosocial risk factors for physical and mental health outcomes and course of depression among depressed patients
J Consult Clin Psychol
The twelve-month outcome of patients with neurotic illness in general practice
Psychol Med
Anxiety syndromes as epiphenomena of primary major depressionoutcome and familial psychopathology
Am J Psychiatry
Anxiety and depressiondiscrete diagnostic entities?
J Clin Psychopharmacol
Cited by (105)
Approach to Diagnosis and Management of Treatment-Resistant Depression
2023, Psychiatric Clinics of North AmericaDepression and anxiety among individuals with medical conditions during the COVID-19 pandemic: Findings from a nationwide survey in Bangladesh
2021, Acta PsychologicaCitation Excerpt :As smoking is the most preventable cause of death in Bangladesh (Islam & Walton, 2019), targeting depression and anxiety in conjunction with smoking cessation efforts is important among people with medical concerns. This current study also found a strong relationship between depression and anxiety, similar to findings in people with heart failure (Årestedt et al., 2014) and in other populations (DiMatteo et al., 2000; Gaynes et al., 1999; Hiller et al., 1989). However, our study found no significant association between depression and anxiety and age or marital status, seemingly different from a prior report and possibly reflecting participant differences or other factors (Islam et al., 2015).
Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders
2019, Journal of Affective DisordersCitation Excerpt :Several studies showed that anxiety symptoms are common in patients with a major depressive episode (MDE) (Goldberg and Fawcett, 2012; Shaffer et al., 2012; Gaspersz et al., 2018) and are associated with greater depression severity (VanValkenburg et al., 1984; Joffe et al., 1993; Fava et al., 2004, 2006; Dold et al., 2017), higher suicide risk (Sareen et al., 2005; Fava et al., 2006; Goes et al., 2012; Seo et al., 2011; Goldberg and Fawcett, 2012; Fawcett, 2013; McIntyre et al., 2016), more side effects, poor compliance and poor treatment outcome (VanValkenburg et al., 1984; Joffe et al., 1993; Levitt et al., 1993; Davidson et al., 2002; Fava et al., 1997, 2008; Howland et al., 2009; Domschke et al., 2010; Papakostas et al., 2010; Wu et al., 2013; Ionescu et al., 2014; Gaspersz et al., 2017a), greater functional disability (Joffe et al., 1993; Fichter et al., 2010; Goldberg and Fawcett, 2012; Lin et al., 2014) and worse longitudinal course (VanValkenburg et al., 1984; Sherbourne and Wells, 1997; Gaynes et al., 1999; Brown et al., 2000; Melartin et al., 2004; Fitcher et al., 2010; Rhebergen et al., 2011; Meier et al., 2015; Gaspersz et al., 2018).
What is anxious depression? Overlap and agreement between different definitions
2019, Journal of Psychiatric ResearchCitation Excerpt :At least half of depressed patients are diagnosed with a co-occurring anxiety disorder (Fava et al., 2000a; Simon et al., 2003; Zimmerman et al., 2000), and an even larger proportion have elevated scores on dimensional measures of anxiety (Chan et al., 2012). Compared to depressed patients without anxiety, depressed patients with high levels of anxiety are characterized by higher levels of suicidal ideation and history of suicide attempts (Fava et al., 2006; Goes et al., 2010; Sareen et al., 2005; Seo et al., 2011), poorer functioning (Fichter et al., 2010; Lin et al., 2014), poorer health-related quality of life (Lin et al., 2014; Rhebergen et al., 2011), and greater chronicity (Brown et al., 2000; Coryell et al., 1988; Fichter et al., 2010; Gaynes et al., 1999; Grunhaus, 1988; Melartin et al., 2004; Rhebergen et al., 2011; Shankman and Klein, 2002; Sherbourne and Wells, 1997; VanValkenburg et al., 1984). Treatment studies of major depressive disorder (MDD) have found that the presence of high levels of anxiety are associated with poorer response to treatment (Fava et al., 2008; Howland et al., 2009; Papakostas and Larsen, 2011), poorer response to placebo (Trivedi et al., 2018), and differential response to medication (Davidson et al., 2002; Papakostas et al., 2008), though other studies have not found that anxiety predicts treatment response (Nelson, 2010) or differential treatment response (Russell et al., 2001; Simon et al., 1998).
Longitudinal impact of anxiety on depressive outcomes in patients with acute coronary syndrome: Findings from the K-DEPACS study
2017, Psychiatry ResearchCitation Excerpt :In patients with depressive disorders at baseline, comorbid anxiety was significantly associated with persistent depression at the follow-up assessment. This finding supports previous reports on patients with all types of depression, in that coexisting anxiety disorder was a risk factor for persistent depression (Gaynes et al., 1999). Moreover, baseline anxiety was also independently associated with persistent depression at 6 months among depressed patients with ACS (Celano et al., 2012).
- ∗
Dr. Broadhead is deceased.